Factors associated with the uric acid-lowering effects of sodium-glucose cotransporter-2 inhibition in patients with type 2 diabetes: Insights from the randomized PROTECT trial.
Yuichi SaitoAtsushi TanakaTakumi ImaiShin-Ichiro MiuraMasayoshi AjiokaKazuhisa KodamaYoshio KobayashiKoichi Nodenull nullPublished in: Diabetes, obesity & metabolism (2023)